UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patients
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
-
-
U.S. Military Makes Flu Vaccine Optional
On Apr. 21, 2026, the annual influenza vaccines are no longer mandatory, said Pete Hegseth in a video…
-
Biotechnology | Diagnostics | Genomics | Infectious Disease | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Trump administration drops court fight to cap NIH payments for research overhead costs
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
Life Science Industry’s Rapid Growth in Washington State Challenged by NIH Budget Cuts
On Apr. 7, 2026, LifeScienceHistory.com, formerly WashingtonLifeScience.com, announces release of a report highlighting the challenges of Washington State’s…
-
Artificial Intelligence | Biotechnology | Cloning | CRISPR | Diagnostics | Genomics | Implants | Infectious Disease | Life Science History | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Pharmaceutical | Quantum | Therapeutics | U.S. Congress
China Tops U.S. in R&D Spending
On Mar. 31, 2026, the Organisation for Economic Co-operation and Development (OECD), reports that China has officially crept…
-
Artificial Intelligence | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | Pharmaceutical | Therapeutics
China biotech deals hit record as innovative drugs draw interest of multinationals
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
-
Biotechnology | Clinical Research | Diagnostics | Environmental | Infectious Disease | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine
NIH restrictions on foreign research partnerships significantly impacted 1 in 4 U.S. scientists
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
-
US measles cases top 1,500 as Texas outbreak grows
On Mar. 27, 2026, measles cases in the United States have climbed to 1,575, with 88 new infections,…
-
Largest Animal Health Emergency in U.S. History Continues as HPAI Devastates Indiana
On Mar. 26, 2026, Indiana’s poultry industry continues to face significant challenges as outbreaks of highly pathogenic avian…
-
WHO Data Show Pertussis (Whooping Cough) Rising in Western Pacific and Europe
On Mar. 25, 2026, according to the latest data published by the World Health Organization (WHO), globally, 941,582…
-
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 24, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
Largest Animal Health Emergency in U.S. History Continues as HPAI Devastates Indiana
On Mar. 23, 2026, it was reported that since the beginning of March, highly pathogenic avian influenza has…
-
Biotechnology | CDC | Infectious Disease | NIH | Vaccine | WHO
Danish university places hold on controversial U.S. CDC hepatitis B vaccine study in Guinea-Bissau
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
-
Biotechnology | CDC | Clinical Research | COVID-19 | Diagnostics | Genomics | Infectious Disease | Vaccine
CDC Reports Detection and Surveillance of New SARS-CoV-2 Variant BA.3.2
On Mar. 19, 2026, the U.S. Centers for Disease Control and Prevention announced that as of February 11,…
-
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
-
GSK’s RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18–49 years at increased risk
On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…
-
Dengue vaccine remains 80.5% effective against severe cases after five years
On Mar. 11, 2026, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, with…
-
FDA Issues Emergency Use Authorization for Topical Spray to Prevent and Treat New World Screwworm in Multiple Species
On Mar. 10, 2026, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…
-
WHO releases first-ever implementation handbook to accelerate country action on hepatitis elimination
On Mar. 10, 2026, the World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis…
-
Emerging cattle disease spreads to 60 Missouri counties
On Mar. 2, 2026, first reported two years ago, Theileria orientalis is moving westward, with no antibiotics on…
-
EMA recommends Moderna’s combined mRNA vaccine for protecting older adults against COVID-19 and flu
On Feb. 27, 2026, the European Medicines Agency (EMA) announced it’s recommending marketing authorization for mCombriax, Moderna’s combined…
-
First Cases of Highly Pathogenic Avian Influenza in Northern Elephant Seals Confirmed in California
On Feb. 25, 2026, seven weaned elephant seal pups in California’s Año Nuevo State Park tested positive for…
-
CDC | Diagnostics | Infectious Disease | Measles | NIH | Vaccine
Report Details health and economic repercussions of declining MMR coverage in the U.S.
On Feb. 20, 2026, a research study lead by the Yale School of Public Health shows the resurgence…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | NIH | Vaccine
CDC Reported 10,000–23,000 RSV deaths in 2025
On Feb. 19, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported severe outcomes from COVID-19…
-
Biotechnology | CDC | Diagnostics | Environmental | Infectious Disease | Measles | Vaccine
Oregon wastewater dashboard Confirms measles outbreak
On Feb. 19, 2026, a new data tracking tool Oregon Health Authority (OHA) has been launched that shows the five confirmed measles cases identified in the…
-
Study Shows SARS-CoV-2 RNA found in 39% of hospital air samples during outbreaks, despite good ventilation
On Feb. 17, 2026, a new study published in Respiratory Medicine show COVID-19 genetic material was frequently detected in…
-
Scientists develop first-of-its-kind antibody to block Epstein Barr virus
On Feb. 17, 2026, Fred Hutch Cancer Center scientists announced reaching a crucial milestone in blocking Epstein Barr…
-
Biotechnology | CDC | Infectious Disease | Plague | Vaccine | WHO
WHO Issued statement criticizing Ethics of CDC-funded study of hepatitis B vaccine in Guinea-Bissau
On Feb. 13, 2026, the World Health Organization (WHO) underscores that the hepatitis B birth dose vaccine is…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
South Carolina Reports 13 New Measles Cases, Bringing Outbreak total to 933
On Feb. 10, 2026, The South Carolina Department of Public Health (DPH) is reporting 13 new cases of…
-
CDC | COVID-19 | Infectious Disease | Influenza | NIH | U.S. Congress | Vaccine
Study Finds Declining Perceptions of Safety of Covid-19, Flu, and MMR Vaccines
On Feb. 10, 2026, an Annenberg survey finds that a sizable majority of Americans think the three vaccines…
